Exact Mass: 429.1609852000001

Exact Mass Matches: 429.1609852000001

Found 58 metabolites which its exact mass value is equals to given mass value 429.1609852000001, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Pizotifen malate

C23H27NO5S (429.1609852000001)

Pizotifen malate (Pizotyline malate) is a potent 5-HT2 receptor antagonist, with a high affinity for 5-HT1C binding site.

StemRegenin 1

4-(2-{[2-(1-benzothiophen-3-yl)-9-(propan-2-yl)-9H-purin-6-yl]amino}ethyl)phenol

C24H23N5OS (429.1623228)

Cys Asn Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C17H27N5O6S (429.1681962)

Cys Pro Asn Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C17H27N5O6S (429.1681962)

Cys Pro Pro Asn

(2S)-2-{[(2S)-1-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C17H27N5O6S (429.1681962)

Asn Cys Pro Pro

(2S)-1-{[(2S)-1-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C17H27N5O6S (429.1681962)

Asn Pro Cys Pro

(2S)-1-[(2R)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C17H27N5O6S (429.1681962)

Asn Pro Pro Cys

(2R)-2-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C17H27N5O6S (429.1681962)

Pro Cys Asn Pro

(2S)-1-[(2S)-3-carbamoyl-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]propanoyl]pyrrolidine-2-carboxylic acid

C17H27N5O6S (429.1681962)

Pro Cys Pro Asn

(2S)-3-carbamoyl-2-{[(2S)-1-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C17H27N5O6S (429.1681962)

Pro Asn Cys Pro

(2S)-1-[(2R)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C17H27N5O6S (429.1681962)

Pro Asn Pro Cys

(2R)-2-{[(2S)-1-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C17H27N5O6S (429.1681962)

Pro Pro Cys Asn

(2S)-3-carbamoyl-2-[(2R)-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]propanoic acid

C17H27N5O6S (429.1681962)

Pro Pro Asn Cys

(2R)-2-[(2S)-3-carbamoyl-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}propanamido]-3-sulfanylpropanoic acid

C17H27N5O6S (429.1681962)

Amicycline

C21H23N3O7 (429.1535928)

C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic

FMoc-4-Acetyl-L-phenylalanine

C26H23NO5 (429.15761480000003)

Phenactropinium chloride

C24H28ClNO4 (429.1706758000001)

FLORIFENINE

C23H22F3N3O2 (429.1664028)

2-(((1-(TERT-BUTOXY)-2-METHYL-1-OXOPROPAN-2-YL)OXY)IMINO)-2-(2-((TERT-BUTOXYCARBONYL)AMINO)THIAZOL-4-YL)ACETIC ACID

C18H27N3O7S (429.1569632)

2-(2-ETHOXY-1-BUTENYL)-5-PHENYL-3-(3-SULFOBUTYL)BENZOXAZOLIUM INNER SALT

C23H27NO5S (429.1609852000001)

7-Didemethyl Minocycline

C21H23N3O7 (429.1535928)

Kudzu Root P.E

C24H28ClNO4 (429.1706758000001)

methyl 1-[(2-carbamoylbiphenyl-4-yl)methyl]-2-ethoxybenzimidazole-7-carboxylate

C25H23N3O4 (429.16884780000004)

FMOC-DL-4-ACETYLPHENYLALANINE

C26H23NO5 (429.15761480000003)

3-Methoxymethoxy-2-tributylstannylpyridine

C19H35NO2Sn (429.168964)

3,8-DI-(ETHOXYCARBONYLAMINO)-6-PHENYLPHENANTHRIDINE

C25H23N3O4 (429.16884780000004)

StemRegenin 1

C24H23N5OS (429.1623228)

Serratiochelin

C21H23N3O7 (429.1535928)

Thioxanthene-2-sulfonamide, N,N-dimethyl-9-(3-(1-piperazinyl)propylidene)-, (E)-

C22H27N3O2S2 (429.1544602)

[4-(4-Acetylamino-phenyl)-3,5-dioxo-4-aza-tricyclo[5.2.2.0 2,6]undec-1-ylcarbamoyloxy]-acetic acid

C21H23N3O7 (429.1535928)

2-{[(6-Oxo-1,6-Dihydropyridin-3-Yl)methyl]amino}-N-[4-Propyl-3-(Trifluoromethyl)phenyl]benzamide

C23H22F3N3O2 (429.1664028)

Ipratropium bromide hydrate

C20H32BrNO4 (429.15145720000004)

D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents

N-phenyl-5-(7-piperidin-4-yloxyisoquinolin-6-yl)thiophene-2-carboxamide

C25H23N3O2S (429.1510898)

2-[[4-(4-fluorophenyl)-5-[(1-methyl-2-pyrrolyl)methyl]-1,2,4-triazol-3-yl]thio]-N-(2-oxolanylmethyl)acetamide

C21H24FN5O2S (429.1634656)

N-(2-ethylphenyl)-2-[[2-(4-methoxyphenyl)-4-oxo-1-benzopyran-6-yl]oxy]acetamide

C26H23NO5 (429.15761480000003)

N-[2-methoxy-5-(3-methyl-4-oxo-1-phthalazinyl)phenyl]-2-(4-methylphenoxy)acetamide

C25H23N3O4 (429.16884780000004)

{[(1r,7r)-4-(4-Acetamidophenyl)-3,5-dioxo-4-azatricyclo[5.2.2.0(2,6)]undec-1-yl]carbamoyloxy}acetic acid

C21H23N3O7 (429.1535928)

2-[[(4-ethoxyphenyl)-oxomethyl]amino]acetic acid [2-(9H-fluoren-3-yl)-2-oxoethyl] ester

C26H23NO5 (429.15761480000003)

3-[4-[(1R,5S)-3-(2-methylphenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzonitrile

C25H23N3O2S (429.1510898)

4-[4-[(1S,5R)-3-(phenylmethyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzonitrile

C25H23N3O2S (429.1510898)

4-[4-[(1R,5S)-3-(2-methylphenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzonitrile

C25H23N3O2S (429.1510898)

[(1S,2aS,8bS)-2-(1,3-benzodioxol-5-ylmethyl)-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(3-pyridinyl)methanone

C25H23N3O4 (429.16884780000004)

[(1R,2aR,8bR)-2-(1,3-benzodioxol-5-ylmethyl)-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(3-pyridinyl)methanone

C25H23N3O4 (429.16884780000004)

[(1S,2aR,8bR)-2-(1,3-benzodioxol-5-ylmethyl)-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(3-pyridinyl)methanone

C25H23N3O4 (429.16884780000004)

[(1R,2aS,8bS)-2-(1,3-benzodioxol-5-ylmethyl)-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(3-pyridinyl)methanone

C25H23N3O4 (429.16884780000004)

2-[(2R,4aR,12aR)-5-methyl-8-[[(5-methyl-3-isoxazolyl)-oxomethyl]amino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid

C21H23N3O7 (429.1535928)

Benzylpenicilloyl-butylamine sodium

C20H28N3NaO4S (429.1698128000001)

2-[(E)-(2-oxo-1H-indol-3-ylidene)amino]-N-(2-phenylethyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide

C25H23N3O2S (429.1510898)

Ipratropium (bromide hydrate)

C20H32BrNO4 (429.15145720000004)

Ipratropium bromide (Sch 1000) hydrate is a muscarinic receptor antagonist, with IC50s of 2.9 nM, 2 nM, and 1.7 nM for M1, M2, and M3 receptors, respectively. Ipratropium bromide hydrate relaxes smooth muscle, can be used in the research for COPD (chronic obstructive pulmonary disease) and asthma[1][2][3][4][5].

2-[(1-hydroxy-2-{[hydroxy(5-hydroxy-3,4-dihydro-2h-pyrrol-2-yl)methylidene]amino}-3-(c-hydroxycarbonimidoyl)propylidene)amino]-3-(1h-indol-3-yl)propanoic acid

C20H23N5O6 (429.1648258)